innoVactiv commercializes a growing range of nutraceutical ingredients whose efficacy is demonstrated in clinical trials:
 |
|
Human Clinical Study
Results available! |
InSea²™ is the only product on the market today that exhibits a dual mechanism of action against the two digestive enzymes involved in the digestion and assimilation of carbohydrates ingested during a meal. From natural origin, InSea²™ is an optimized blend of polyphenols derived from two species of brown seaweeds. In clinical study, InSea²™ significantly decreased blood glucose and insulin peaks that follow a high carbohydrate meal. InSea²™ may thus be used in formulations of natural health products aiming at reducing the glycemic index of foods.
 |
|
Human Clinical Study
Results available! |
PeptiBal™ is a unique patented ingredient from marine origin able to maintain the balance needed for optimal immune homeostasis. It has a triple stimulating effect. PeptiBal™ is mainly active at the mucosal level, these fine membranes covering our respiratory and digestive tracts and which are there to protect us from microbial invasions. In clinical trial, PeptiBal™ has significantly increased the synthesis of antibodies specialized in mucosal defence. PeptiBal™ also improves tight junctions to help fortify the physical barrier of the intestines. Finally, PeptiBal™ provides a more efficient reaction of the immune system in order to assist the body in its constant fight against invaders.
Please contact us to receive additional information documents or if you have questions about our nutraceutical ingredients InSea²™ and PeptiBal™.
Our ingredients are included in these products:
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
